1. Home
  2. RGEN vs CGNX Comparison

RGEN vs CGNX Comparison

Compare RGEN & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • CGNX
  • Stock Information
  • Founded
  • RGEN 1981
  • CGNX 1981
  • Country
  • RGEN United States
  • CGNX United States
  • Employees
  • RGEN N/A
  • CGNX N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • CGNX Industrial Machinery/Components
  • Sector
  • RGEN Health Care
  • CGNX Industrials
  • Exchange
  • RGEN Nasdaq
  • CGNX Nasdaq
  • Market Cap
  • RGEN 7.6B
  • CGNX 7.0B
  • IPO Year
  • RGEN N/A
  • CGNX 1989
  • Fundamental
  • Price
  • RGEN $160.51
  • CGNX $39.73
  • Analyst Decision
  • RGEN Buy
  • CGNX Buy
  • Analyst Count
  • RGEN 12
  • CGNX 12
  • Target Price
  • RGEN $187.44
  • CGNX $47.92
  • AVG Volume (30 Days)
  • RGEN 521.6K
  • CGNX 1.2M
  • Earning Date
  • RGEN 02-19-2025
  • CGNX 02-13-2025
  • Dividend Yield
  • RGEN N/A
  • CGNX 0.81%
  • EPS Growth
  • RGEN N/A
  • CGNX N/A
  • EPS
  • RGEN N/A
  • CGNX 0.51
  • Revenue
  • RGEN $633,513,000.00
  • CGNX $881,501,000.00
  • Revenue This Year
  • RGEN $2.28
  • CGNX $10.30
  • Revenue Next Year
  • RGEN $9.88
  • CGNX $11.28
  • P/E Ratio
  • RGEN N/A
  • CGNX $77.99
  • Revenue Growth
  • RGEN N/A
  • CGNX 0.14
  • 52 Week Low
  • RGEN $113.50
  • CGNX $34.79
  • 52 Week High
  • RGEN $211.13
  • CGNX $53.13
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 62.61
  • CGNX 65.04
  • Support Level
  • RGEN $150.23
  • CGNX $36.49
  • Resistance Level
  • RGEN $160.64
  • CGNX $37.81
  • Average True Range (ATR)
  • RGEN 6.76
  • CGNX 0.99
  • MACD
  • RGEN 1.14
  • CGNX 0.48
  • Stochastic Oscillator
  • RGEN 80.27
  • CGNX 95.09

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's own cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Share on Social Networks: